Cargando…
Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals With Presymptomatic Type 1 Diabetes
In our previous data-driven analysis of evolving patterns of islet autoantibodies (IAb) against insulin (IAA), GAD (GADA), and islet antigen 2 (IA-2A), we discovered three trajectories, characterized according to multiple IAb (TR1), IAA (TR2), or GADA (TR3) as the first appearing autoantibodies. Her...
Autores principales: | Kwon, Bum Chul, Achenbach, Peter, Anand, Vibha, Frohnert, Brigitte I., Hagopian, William, Hu, Jianying, Koski, Eileen, Lernmark, Åke, Lou, Olivia, Martin, Frank, Ng, Kenney, Toppari, Jorma, Veijola, Riitta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750947/ https://www.ncbi.nlm.nih.gov/pubmed/36112006 http://dx.doi.org/10.2337/db22-0360 |
Ejemplares similares
-
Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories
por: Kwon, Bum Chul, et al.
Publicado: (2022) -
Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
por: Ng, Kenney, et al.
Publicado: (2022) -
Childhood Height Growth Rate Association With the Risk of Islet Autoimmunity and Development of Type 1 Diabetes
por: Li, Zhiguo, et al.
Publicado: (2022) -
HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children
por: Salami, Falastin, et al.
Publicado: (2022) -
Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFA
por: Martinez, Maria Månsson, et al.
Publicado: (2020)